Elderly group (≧80, n=44) | Younger group (<80, n=146) | p-value | |
---|---|---|---|
Age, median (range) | 83 (80–92) | 65 (41–79) | <0.001 |
Sex (male to female) | 37:7 | 130:16 | 0.378 |
BMI median (range) | 22.9 (15.4–30.4) | 23.5 (16.5–35.5) | 0.083 |
ASA score (1/2/3) | 12/5/27 | 46/33/67 | 0.137 |
CCI class (0/1/2/3) | 9/19/11/5 | 32/72/40/2 | 0.053 |
Hb, g/L median (range) | 119 (63–157) | 126 (53–169) | 0.015 |
Alb, g/L median (range) | 36.9 (31.3–59.3) | 37.6 (24.4–47.3) | 0.146 |
Operating time, min median (range) | 308 (160–480) | 399 (235–670) | <0.001 |
EBL, ml median(range) | 300 (100–1400) | 406 (100–1900) | 0.475 |
Transfusion, n (%) | 21 (47.7) | 41 (28.1) | 0.015 |
PLND, n (%) | 33 (75.0) | 130 (89.0) | 0.019 |
Number of lymph node, n median (range) | 13 (1–29) | 15 (1–39) | 0.274 |
Urinary diversion, n (%) | 0.051 | ||
 Ileal conduit | 25 (56.8) | 95 (65.1) | |
 Ileal neobladder | 0 (0) | 10 (6.8) | |
 Ureterostomy | 19 (43.2) | 41 (28.1) | |
cT (cT2 over) n, (%) | 21 (47.7) | 52 (35.6) | 0.148 |
cT (Tis/a/1/2/3/4) | 0/2/8/13/13/8 | 7/7/44/36/40/12 | 0.201 |
cN(+) n, (%) | 6 (13.6) | 36 (24.7) | 0.122 |
LVI(+) n, (%) | 17 (38.6) | 54 (35.5) | 0.843 |
Positive surgical margin, n (%) | 2 (4.5) | 6 (4.1) | 1.000 |
Postoperative hospital stay, days median (range) | 12 (7–29) | 15 (6–39) | 0.437 |
Complications according to Clavien–Dindo, n (%) | 0.605 | ||
 0 | 22 (50.0) | 66 (45.2) | |
 1–2 | 18 (40.9) | 71 (48.6) | |
 3–5 | 4 (9.1) | 9 (6.2) | |
90-day mortality, n (%) | 3 (6.8) | 3 (2.1) | 0.275 |